Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virpax Pharmaceuticals, Inc.

0.2750
+0.01505.77%
Volume:7.13K
Turnover:2.01K
Market Cap:341.69K
PE:0.00
High:0.3000
Open:0.2550
Low:0.2550
Close:0.2600
Loading ...

BUZZ-Virpax Pharma plunges as Nasdaq delisting looms

Reuters
·
03 Apr

Virpax Pharmaceuticals Faces Nasdaq Delisting Notice and Leadership Changes

TIPRANKS
·
03 Apr

Virpax Pharmaceuticals Inc - Usama Chaudhry Resigns as CFO - SEC Filing

THOMSON REUTERS
·
03 Apr

Virpax Pharmaceuticals Inc - Nasdaq to File Form 25 for Virpax Pharmaceuticals Delisting

THOMSON REUTERS
·
03 Apr

Virpax Pharmaceuticals : Does Not Intend to Request Review of Panel's Decision by Nasdaq Listing and Hearing Review Council

THOMSON REUTERS
·
03 Apr

BRIEF-Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock

Reuters
·
25 Mar

Virpax Pharmaceuticals Inc trading halted, news pending

TIPRANKS
·
21 Mar

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Rate Decision

MT Newswires Live
·
19 Mar

Virpax Pharmaceuticals announces 1-for-25 reverse stock split

TIPRANKS
·
19 Mar

Virpax Pharmaceuticals Announces Reverse Stock Split

THOMSON REUTERS
·
19 Mar

Virpax Pharmaceuticals Inc - to Effect 1-for-25 Reverse Stock Split

THOMSON REUTERS
·
19 Mar

Virpax Pharmaceuticals Announces Reverse Stock Split

Business Wire
·
19 Mar

Virpax Reports Positive Results From Dose Range Finding Study of Pain Relief Treatment in Beagle Dogs

MT Newswires Live
·
19 Mar

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in Ind

THOMSON REUTERS
·
19 Mar

Virpax Pharmaceuticals Inc - Doses of Lbl100 up to 90 Mg/Kg Well Tolerated by Beagle Dogs

THOMSON REUTERS
·
19 Mar

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Business Wire
·
19 Mar

BRIEF-Virpax Looking To Use Met To Develop Intranasal Covid Vaccine

Reuters
·
07 Mar

Virpax Pharmaceuticals Inc - to Explore Intranasal Vaccine Delivery

THOMSON REUTERS
·
07 Mar

Virpax Looking to Use Met to Develop Intranasal Covid Vaccine

THOMSON REUTERS
·
07 Mar

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Business Wire
·
07 Mar